ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Veradigm Increasing Presence in Payer Market

Company uniquely positioned to drive increased value

Veradigm Inc. (NASDAQ: MDRX) reports today strong growth for the preceding six months in its payer segment including:

  • 296 Veradigm Payerpath agreements
  • 6 net-new regional payer, national payer, and aggregator clients signed
  • 16 incremental health plan agreements signed with existing clients, including the new Comprehensive Submissions which increased Veradigm’s footprint in the Medicaid market
  • Signed the first two Veradigm Payer Insight contracts, breaking ground in the company’s ability to display gaps in care alerts in a single consolidated workflow on behalf of health plans for their providers

Veradigm Payerpath was recently rated top end-to-end revenue cycle management (RCM) software by Black Book. Veradigm Payerpath is an end-to-end provider/payer collaboration platform built to handle clean claims submissions, assist organizations to improve revenue, reduce friction between payers and providers, and streamline patient communications.

Veradigm added 6 net-new regional payer, national payer, and aggregator clients, while expanding business with 15 current clients, worth multimillion in annual contract value. Veradigm also grew its Blue Cross/Blue Shield health plan client base to 10 by adding one additional large Blue health plan.

“To compete effectively while also improving clinical and financial outcomes, payers need to drive new, meaningful value for their members and their network of providers,” said Tom Langan, President and Chief Commercial Officer of Veradigm. “Doing so calls for a comprehensive, end-to-end solution that empowers payers to deliver the meaningful improvements their members want and need.”

Veradigm has also experienced significant growth in Veradigm Payer Analytics which is a comprehensive solution that supports payers’ risk adjustment and quality efforts to help close quality gaps and enhance financial performance, improve risk and quality scores, and deploy the right intervention, with the right provider, at the right time.

Veradigm is making strides in engaging customers and prospects with a full suite of end-to-end solutions. The Company is navigating EDI cross-sell opportunities with two large health plan clients and was verbally awarded Vendor of Choice (VOC) status from a 4.5-Star health care system to provide Health Plan analytics and Provider Engagement solutions, with the potential to include Submissions as well as expand current Clearinghouse contracts.

“We believe that Veradigm is uniquely positioned to drive value by combining a proven, end-to-end solution with provider and member engagement solutions to support payer strategic objectives,” said Rick Poulton, Veradigm Chief Executive Officer. “Only Veradigm combines a comprehensive offering with a large-scale provider network, patented technology and methodology, along with third-party validation of the effectiveness of our solutions.”

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully. For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube

© 2023 Veradigm Inc. and/or its affiliates. All Rights Reserved.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.